Sign inJoin waitlistJoin the waitlist

SE

Samuel Ejadi

Medical Oncology

Credentials: · · · · ·

History

Hematology and Medical Oncology
1999–2002
Internal Medicine
1996–1999
Rutgers, Robert Wood Johnson Medical School
1992–1996

Research

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
British Journal of Cancer · 2020 · 796 citations
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
Journal of Clinical Oncology · 2017 · 378 citations
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
Annals of Oncology · 2018 · 301 citations

RC
Roger Cohen
3 papers
Sarina Piha-Paul
3 papers
JS
Jasgit Sachdev
2 papers
JW
John Wallmark
2 papers
Mark Stein
2 papers
Patrick Ott
2 papers
Alain Algazi
1 paper
AH
Alan Houghton
1 paper
AS
Aleksandar Sekulic
1 paper
Allison Dobry
1 paper · 1 as a resident
Amit Mahipal
1 paper
AP
Amita Patnaik
1 paper